|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
41st Annual Meeting in Savannah, Georgia
Let me be one of the first to invite you to the 41st Annual ASHI Meeting. As program planning chair, and just finishing the first committee meeting, I would like to take this time to accomplish a few things.
First, Savannah, Georgia, is going to be a great backdrop or venue for this meeting. Southern hospitality, basic or upscale comfort food, history and architecture and let’s not forget, some great golfing. A short ferry ride from the convention center to the heart of Savannah and the adventures begin.
Second, don’t plan your airline schedule yet, the meeting format is going to be a little bit different. We will start with the Rose Payne lecture and then a Welcome Reception. We will be having two poster receptions with the second being on Thursday evening. It will be preceded with a session that will remind us why we do what we do and then time to give the posters a final review, enjoy refreshments and engage our colleagues.
Third, Friday’s session will be real plenary sessions that have the science and practical base we need to deliver histocompatibility support our transplant programs and patients expect.
So, once again, wait for the full meeting schedule to come out before you make your travel plans, we wouldn’t want you to miss the sessions you want to attend.
John A. Gerlach, Ph.D., D(ABHI)
Professor and Program Director
Biomedical Laboratory Diagnostics Program
| Share this article:
2015 Call for ASHI Board Nominations — Deadline May 4|
The ASHI Nominations Committee encourages all ASHI members to nominate candidates for the available officer and board positions. If there are candidates you feel would be an asset to the ASHI Board of Directors, please complete and submit this nomination form to ASHI. All nominations must be accompanied by the signatures of at least 10 full or honorary members in good standing. Email endorsements are acceptable.|
By March 23, the Nominations Committee will forward its preliminary slate of candidates to the ASHI membership. This will allow members time to submit additional nominations by the May 4, deadline.
ASHI 2014 Standards
The final version of the 2014 ASHI standards with guidance has been approved by CMS and is posted on the ASHI website.
OPTN Policy Requirements for Informed Consent and Psychosocial and Medical Evaluation for Living Donors
UNOS provided information about a new OPTN Policy Requirements for Informed Consent and Psychosocial and Medical Evaluation for Living Donors recording and learning pathway. The recording is approximately 25 minutes long and can be accessed here.
After viewing the recording, access the evaluation and assessment here. For those interested in receiving credit for participation, ABTC will award 0.5 Category 1 CEPTC credit. To receive credit, you must pass the assessment. The assessment may be taken more than once. If you do not wish to receive CEPTC credit, taking the assessment is not necessary. CEPTCs are available until July 15.
Learn more here.
MISS AN ISSUE OF ASHI INSIGHTS? |
Click here to visit the ASHI Insights archive page.
FOCIS 2015: Abstract Submission and Registration is Open
Abstract submission deadline is Wednesday, Jan. 28.
FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and apply ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study. Click here for more information.
Workshop 1: San Antonio, Texas - Thursday, April 30 - Saturday, May 2
Workshop 2: Philadelphia, Pennsylvania - Thursday, June 18 - Saturday, June 20
For more information on the ASHI Regional Education Workshops, please visit the Regional Meetings page.
OPTN/UNOS Instructional Offering
The Instructional Innovations department at UNOS is interested in how you prefer to receive instructional offerings.
Please take a few minutes to scan the QR code and complete the survey from your mobile device.
In the event you cannot access the QR code, try this link to complete the survey.
HLA-G and susceptibility to develop celiac disease
The Human Leukocyte Antigen-G has immunomodulatory function and its expression has been associated with several diseases. In this study scientists analyzed HLA-G polymorphisms in order to evaluate their possible association with susceptibility to celiac disease development. A total of 420 celiac patients and 509 controls were genotyped for HLA-G polymorphisms.
Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumor immunotherapy
The most potent killing machinery in our immune system is the cytotoxic T lymphocyte. Since the possibility for self-destruction by these cells is high, many regulatory activities exist to prevent autoimmune destruction by these cells. A tumor grows from the cells of the body and is tolerated by the body's immune system.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063